The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status
- PMID: 36924249
- PMCID: PMC10542831
- DOI: 10.3324/haematol.2022.281973
The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status
References
-
- Poon MC, d'Oiron R. Alloimmunization in congenital deficiencies of platelet surface glycoproteins: focus on Glanzmann's thrombasthenia and Bernard-Soulier's syndrome. Semin Thromb Hemost. 2018;44(6):604-614. - PubMed
-
- Novo Nordisk. NovoSeven®, Summary of product characteristics. 2023. https://www.ema.europa.eu/en/documents/product-information/novoseven-epa.... Accessed 20 February 2023.
-
- EMA. Assessment report NovoSeven. https://www.ema.europa.eu/en/documents/variation-report/novoseven-h-c-00.... Accessed 16 March 2023.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical